Automated capillary Western dot blot method for the identity of a 15-valent pneumococcal conjugate vaccine

被引:23
|
作者
Hamm, Melissa [1 ]
Ha, Sha [1 ]
Rustandi, Richard R. [1 ]
机构
[1] Merck Res Labs, Vaccine Analyt Dev, West Point, PA 19486 USA
关键词
Pneumococcal conjugate vaccine; Dot blot; Capillary Western; Simple Western; CRM197; Polysaccharide; POLYSACCHARIDES; QUANTITATION; SYSTEM;
D O I
10.1016/j.ab.2015.03.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Simple Western is a new technology that allows for the separation, blotting, and detection of proteins similar to a traditional Western except in a capillary format. Traditionally, identity assays for biological products are performed using either an enzyme-linked immunosorbent assay (ELISA) or a manual dot blot Western. Both techniques are usually very tedious, labor-intensive, and complicated for multivalent vaccines, and they can be difficult to transfer to other laboratories. An advantage this capillary Western technique has over the traditional manual dot blot Western method is the speed and the automation of electrophoresis separation, blotting, and detection steps performed in 96 capillaries. This article describes details of the development of an automated identity assay for a 15-valent pneumococcal conjugate vaccine, PCV15-CRM197, using capillary Western technology. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [21] CLINICAL IMPACT OF REPLACING 13-VALENT WITH A 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN COSTA RICAN NATIONAL IMMUNIZATION PROGRAM
    Rendon, A. M.
    Herrera-Solano, W.
    Hirata, L.
    White, M.
    Huang, M.
    Weaver, J.
    Chhabra, N.
    Singla, P.
    Kumari, S.
    Parellada, C.
    VALUE IN HEALTH, 2024, 27 (06) : S13 - S14
  • [22] HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE SEROTYPES IN CHILDREN IN THREE EUROPEAN COUNTRIES
    Hu, T.
    Bencina, G.
    Petigara, T.
    Elbasha, E.
    VALUE IN HEALTH, 2019, 22 : S646 - S646
  • [24] Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population
    Huang, Min
    Hu, Tianyan
    Weaver, Jessica
    Owusu-Edusei, Kwame
    Elbasha, Elamin
    VACCINES, 2023, 11 (01)
  • [25] Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain
    Caro-Aguilar, Ivette
    Indrawati, Lani
    Kaufhold, Robin M.
    Gaunt, Christine
    Zhang, Yuhua
    Nawrocki, Denise K.
    Giovarelli, Cecilia
    Winters, Michael A.
    Smith, William J.
    Heinrichs, Jon
    Skinner, Julie M.
    VACCINE, 2017, 35 (06) : 865 - 872
  • [26] A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
    Rupp, R.
    Hurley, D.
    Grayson, S.
    Li, J.
    Nolan, K.
    McFetridge, R. D.
    Hartzel, J.
    Abeygunawardana, C.
    Winters, M.
    Pujar, H.
    Benner, P.
    Musey, L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 549 - 559
  • [27] HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV15) SEROTYPES IN CHILDREN IN THE UNITED STATES
    Hu, T.
    Petigara, T.
    Elbasha, E.
    VALUE IN HEALTH, 2019, 22 : S201 - S201
  • [28] PUBLIC HEALTH IMPACT OF SWITCHING FROM A 13-VALENT TO A 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE CHILEAN NATIONAL IMMUNIZATION PROGRAM
    Hirata, L.
    Wong Ticona, R.
    White, M.
    Huang, M.
    Webster, J.
    Urrego-Reyes, J.
    Chhabra, N.
    Kamboj, H.
    Gotarkar, S.
    Parellada, C.
    VALUE IN HEALTH, 2024, 27 (06) : S158 - S158
  • [29] A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
    Wilck, Marissa
    Barnabas, Shaun
    Chokephaibulkit, Kulkanya
    Violari, Avy
    Kosalaraksa, Pope
    Yesypenko, Svitlana
    Chukhalova, Iryna
    Dagan, Ron
    Richmond, Peter
    Mikviman, Elena
    Morgan, Leslie
    Feemster, Kristen
    Lupinacci, Robert
    Chiarappa, Joseph A.
    Madhi, Shabir
    Bickham, Kara
    Musey, Luwy
    AIDS, 2023, 37 (08) : 1227 - 1237
  • [30] Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2022
    Kobayashi, Miwako
    Farrar, Jennifer L.
    Gierke, Ryan
    Britton, Amadea
    Childs, Lana
    Leidner, Andrew J.
    Campos-Outcalt, Doug
    Morgan, Rebecca L.
    Long, Sarah S.
    Talbot, H. Keipp
    Poehling, Katherine A.
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (04): : 109 - 117